Arteriosclerosis and Thrombosis, Vol 14, 790-797, Copyright © 1994 by American Heart Association
ARTICLES |
K Brand, CL Banka, N Mackman, RA Terkeltaub, ST Fan and LK Curtiss
Department of Immunology, Scripps Research Institute, La Jolla, CA 92037.
Oxidized low-density lipoprotein (oxLDL) has been characterized as an atherogenic molecule responsible for the induction of a variety of gene products. One such gene, tissue factor (TF), the cellular initiator of the coagulation cascade, is not expressed in normal vascular tissue but is expressed by monocytes and foam cells in atherosclerotic lesions. Therefore, we examined the effect of oxLDL on TF expression in cultured human adherent monocytes. Endotoxin-free oxLDL alone did not induce TF expression in adherent monocytes. However, oxLDL significantly enhanced TF expression induced by the inflammatory mediator, bacterial lipopolysaccharide (LPS), in a time- and dose-dependent manner. In contrast, oxLDL did not alter LPS-mediated production of interleukin-8 and actually inhibited LPS-induced secretion of tumor necrosis factor- alpha, suggesting that some aspects of the signaling pathways for TF induction differ from those of other LPS-responsive monocyte/macrophage gene products. Thus, this study documents specific modulation of the expression of LPS-inducible genes in monocytic cells by oxLDL. Factors that enhance TF expression in monocyte/macrophage cells present in atheroma may contribute to the severity of thrombotic episodes and complications observed in atherosclerosis.
This article has been cited by other articles:
![]() |
M. Groeneweg, E. Kanters, M. N. Vergouwe, H. Duerink, G. Kraal, M. H. Hofker, and M. P. J. de Winther Lipopolysaccharide-induced gene expression in murine macrophages is enhanced by prior exposure to oxLDL J. Lipid Res., October 1, 2006; 47(10): 2259 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and L. M. Wahl Synergistic enhancement of cytokine-induced human monocyte matrix metalloproteinase-1 by C-reactive protein and oxidized LDL through differential regulation of monocyte chemotactic protein-1 and prostaglandin E2 J. Leukoc. Biol., January 1, 2006; 79(1): 105 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mandal, A. Iakhiaev, U. R. Pendurthi, and L. V. M. Rao Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol Blood, January 1, 2005; 105(1): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. OSTERUD and E. BJORKLID Role of Monocytes in Atherogenesis Physiol Rev, October 1, 2003; 83(4): 1069 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Watson, A. K. C. Chan, L. R. Berry, J. Li, S. K. Sood, J. G. Dickhout, L. Xu, G. H. Werstuck, L. Bajzar, H. J. Klamut, et al. Overexpression of the 78-kDa Glucose-regulated Protein/Immunoglobulin-binding Protein (GRP78/BiP) Inhibits Tissue Factor Procoagulant Activity J. Biol. Chem., May 2, 2003; 278(19): 17438 - 17447. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Ananyeva, D. V. Kouiavskaia, M. Shima, and E. L. Saenko Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque Blood, May 29, 2002; 99(12): 4475 - 4485. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Koh, M. H. Kang, D. K. Jin, S.-K. Lee, J. Y. Ahn, H. Y. Hwang, S. H. Yang, D. S. Kim, T. H. Ahn, and E. K. Shin Vascular effects of estrogen in type II diabetic postmenopausal women J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1409 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. S. de Villiers, L. Cai, N. R. Webb, M. C. de Beer, D. R. van der Westhuyzen, and F. C. de Beer CD36 does not play a direct role in HDL or LDL metabolism J. Lipid Res., August 1, 2001; 42(8): 1231 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Koh, D. K. Jin, S. H. Yang, S.-K. Lee, H. Y. Hwang, M. H. Kang, W. Kim, D. S. Kim, I. S. Choi, and E. K. Shin Vascular Effects of Synthetic or Natural Progestagen Combined With Conjugated Equine Estrogen in Healthy Postmenopausal Women Circulation, April 17, 2001; 103(15): 1961 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohsawa, T. Koyama, K. Yamamoto, S. Hirosawa, S. Kamei, and R. Kamiyama 1{alpha},25-Dihydroxyvitamin D3 and Its Potent Synthetic Analogs Downregulate Tissue Factor and Upregulate Thrombomodulin Expression in Monocytic Cells, Counteracting the Effects of Tumor Necrosis Factor and Oxidized LDL Circulation, December 5, 2000; 102(23): 2867 - 2872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Penn, M.-Z. Cui, A. L. Winokur, J. Bethea, T. A. Hamilton, P. E. DiCorleto, and G. M. Chisolm Smooth muscle cell surface tissue factor pathway activation by oxidized low-density lipoprotein requires cellular lipid peroxidation Blood, November 1, 2000; 96(9): 3056 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kjalke, A. Silveira, A. Hamsten, U. Hedner, and M. Ezban Plasma Lipoproteins Enhance Tissue Factor-Independent Factor VII Activation Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1835 - 1841. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Corseaux, T. Meurice, I. Six, L. Rugeri, M. D. Ezekowitz, P. Rouvier, R. Bordet, C. Bauters, and B. Jude Basic Fibroblast Growth Factor Increases Tissue Factor Expression in Circulating Monocytes and in Vascular Wall Circulation, April 25, 2000; 101(16): 2000 - 2006. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Akuzawa, M. Kurabayashi, Y. Ohyama, M. Arai, and R. Nagai Zinc Finger Transcription Factor Egr-1 Activates Flt-1 Gene Expression in THP-1 Cells on Induction for Macrophage Differentiation Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 377 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Z. Cui, M. S. Penn, and G. M. Chisolm Native and Oxidized Low Density Lipoprotein Induction of Tissue Factor Gene Expression in Smooth Muscle Cells Is Mediated by Both Egr-1 and Sp1 J. Biol. Chem., November 12, 1999; 274(46): 32795 - 32802. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fischer, S. Page, M. Weber, T. Eisele, D. Neumeier, and K. Brand Differential Effects of Lipopolysaccharide and Tumor Necrosis Factor on Monocytic Ikappa B Kinase Signalsome Activation and Ikappa B Proteolysis J. Biol. Chem., August 27, 1999; 274(35): 24625 - 24632. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Page, C. Fischer, B. Baumgartner, M. Haas, U. Kreusel, G. Loidl, M. Hayn, H. W. L. Ziegler-Heitbrock, D. Neumeier, and K. Brand 4-Hydroxynonenal Prevents NF-{kappa}B Activation and Tumor Necrosis Factor Expression by Inhibiting I{kappa}B Phosphorylation and Subsequent Proteolysis J. Biol. Chem., April 23, 1999; 274(17): 11611 - 11618. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gardner, C. L. Banka, K. A. Roberts, A. E. Mullick, and J. C. Rutledge Modified LDL–Mediated Increases in Endothelial Layer Permeability Are Attenuated With 17ß-Estradiol Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 854 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. E. D. van den Eijnden, J. T. van Noort, L. Hollaar, A. van der Laarse, and R. M. Bertina Cholesterol or Triglyceride Loading of Human Monocyte-Derived Macrophages by Incubation With Modified Lipoproteins Does Not Induce Tissue Factor Expression Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 384 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Engelmann, S. Zieseniss, K. Brand, S. Page, A. Lentschat, A. J. Ulmer, and E. Gerlach Tissue Factor Expression of Human Monocytes Is Suppressed by Lysophosphatidylcholine Arterioscler Thromb Vasc Biol, January 1, 1999; 19(1): 47 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brand, T. Eisele, U. Kreusel, M. Page, S. Page, M. Haas, A. Gerling, C. Kaltschmidt, F.-J. Neumann, N. Mackman, et al. Dysregulation of Monocytic Nuclear Factor-{kappa}B by Oxidized Low-Density Lipoprotein Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1901 - 1909. [Abstract] [Full Text] |
||||
![]() |
V. Toschi, R. Gallo, M. Lettino, J. T. Fallon, S. D. Gertz, A. Fernandez-Ortiz, J. H. Chesebro, L. Badimon, Y. Nemerson, V. Fuster, et al. Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques Circulation, February 4, 1997; 95(3): 594 - 599. [Abstract] [Full Text] |
||||
![]() |
J. A. Berliner, M. Navab, A. M. Fogelman, J. S. Frank, L. L. Demer, P. A. Edwards, A. D. Watson, and A. J. Lusis Atherosclerosis: Basic Mechanisms : Oxidation, Inflammation, and Genetics Circulation, May 1, 1995; 91(9): 2488 - 2496. [Abstract] [Full Text] |
||||
![]() |
S. Zieseniss, S. Zahler, I. Muller, A. Hermetter, and B. Engelmann Modified Phosphatidylethanolamine as the Active Component of Oxidized Low Density Lipoprotein Promoting Platelet Prothrombinase Activity J. Biol. Chem., June 1, 2001; 276(23): 19828 - 19835. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kubo-Inoue, K. Egashira, M. Usui, M. Takemoto, K. Ohtani, M. Katoh, H. Shimokawa, and A. Takeshita Long-term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1478 - H1484. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |